Chronic lymphocytic leukemia cells bind and present the erythrocyte protein band 3: Possible role as initiators of autoimmune hemolytic anemia

Journal of Immunology

Volumn 181, Issue 5, 2008, Pages 3674-3683

  Galletti, Jeremías ^a   Cañones, Cristian ^a   Morande, Pablo ^a   Borge, Mercedes ^a   Oppezzo, Pablo ^b   Geffner, Jorge ^a   Bezares, Raimundo ^c   Gamberale, Romina ^a   Giordano, Mirta ^a  

^a ACADEMIA NACIONAL DE MEDICINA   (Argentina)

^b INSTITUT PASTEUR DE MONTEVIDEO   (Uruguay)

^c Hospital General De Agudos Teodoro Alvarez   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; ERYTHROCYTE BAND 3 PROTEIN;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BINDING SITE; CD4+ T LYMPHOCYTE; CELL ASSAY; CELL INTERACTION; CELL PROLIFERATION; CELL STIMULATION; CELL VACUOLE; CHRONIC LYMPHATIC LEUKEMIA; HUMAN; HUMAN CELL; INTERNALIZATION; LEUKEMIA CELL; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; T LYMPHOCYTE ACTIVATION; ANTIGEN PRESENTING CELL; B CELL LEUKEMIA; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED; PATHOLOGY; T LYMPHOCYTE;

AGED; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANION EXCHANGE PROTEIN 1, ERYTHROCYTE; ANTIGEN-PRESENTING CELLS; CELL PROLIFERATION; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTE ACTIVATION; MIDDLE AGED; PROTEIN BINDING; T-LYMPHOCYTES;

EID: 51549116936     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.5.3674     Document Type: Article

References (60)

1. Caligaris-Cappio, F., and T. J. Hamblin. 1999. B-cell chronic lymphocytic leukemia: a bird of a different feather. J. Clin. Oncol. 17: 399-408. (Pubitemid 29022419)
2. Damle, R. N., F. Ghiotto, A. Valetto, E. Albesiano, F. Fais, X. J. Yan, C. P. Sison, S. L. Allen, J. Kolitz, P. Schulman, et al. 2002. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood 99: 4087-4093.
3. Byrd, J. C., S. Stilgenbauer, and I. W. Flinn. 2004. Chronic lymphocytic leukemia. Hematology 2004: 163-183.
4. Barcellini, W., S. Capalbo, R. M. Agostinelli, F. R. Mauro, A. Ambrosetti, R. Calori, A. Cortelezzi, L. Laurenti, E. M. Pogliani, P. Pedotti, et al. 2006. Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia. Haematologica 91: 1689-1692. (Pubitemid 46032967)
5. Mauro, F. R., R. Foa, R. Cerretti, D. Giannarelli, S. Coluzzi, F. Mandelli, and G. Girelli. 2000. Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features. Blood 95: 2786-2792.
6. Hamblin, T. J. 2006. Autoimmune complications of chronic lymphocytic leukemia. Semin. Oncol. 33: 230-239.
7. Leddy, J. P., J. L. Falany, G. E. Kissel, S. T. Passador, and S. I. Rosenfeld. 1993. Erythrocyte membrane proteins reactive with human (warm-reacting) anti-red cell autoantibodies. J. Clin. Invest. 91: 1672-1680.
8. Dearden, C., R. Wade, M. Else, S. Richards, D. Milligan, T. Hamblin, and D. Catovsky. 2008. The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia. Blood 111: 1820-1826.
9. Hall, A. M., M. A. Vickers, E. McLeod, and R. N. Barker. 2005. Rh autoantigen presentation to helper T cells in chronic lymphocytic leukemia by malignant B cells. Blood 105: 2007-2015. (Pubitemid 40731785)
10. Sthoeger, Z. M., M. Wakai, D. B. Tse, V. P. Vinciguerra, S. L. Allen, D. R. Budman, S. M. Lichtman, P. Schulman, L. R. Weiselberg, and N. Chiorazzi. 1989. Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. J. Exp. Med. 169: 255-268. (Pubitemid 19035555)
11. Stamatopoulos, K., C. Belessi, C. Moreno, M. Boudjograh, G. Guida, T. Smilevska, L. Belhoul, S. Stella, N. Stavroyianni, M. Crespo, et al. 2007. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood 109: 259-270. (Pubitemid 46070124)
12. Wang, D. N. 1994. Band 3 protein: structure, flexibility, and function. FEBS Lett. 346: 26-31. (Pubitemid 24183822)
13. Leddy, J. P., S. L. Wilkinson, G. E. Kissel, S. T. Passador, J. L. Falany, and S. I. Rosenfeld. 1994. Erythrocyte membrane proteins reactive with IgG (warmreacting) anti-red blood cell autoantibodies, II: antibodies coprecipitating band 3 and glycophorin A. Blood 84: 650-656.
14. Victoria, E. J., S. W. Pierce, M. J. Branks, and S. P. Masouredis. 1990. IgG red blood cell autoantibodies in autoimmune hemolytic anemia bind to epitopes on red blood cell membrane band 3 glycoprotein. J. Lab. Clin. Med. 115: 74-88.
15. Barker, R. N., K. M. Casswell, M. E. Reid, R. J. Sokol, and C. J. Elson. 1992. Identification of autoantigens in autoimmune haemolytic anaemia by a non-radioisotope immunoprecipitation method. Br. J. Haematol. 82: 126-132.
16. Barker, R. N., G. G. de Sa Oliveira, C. J. Elson, and P. M. Lydyard. 1993. Pathogenic autoantibodies in the NZB mouse are specific for erythrocyte band 3 protein. Eur. J. Immunol. 23: 1723-1726.
17. Winograd, E., J. G. Prudhomme, and I. W. Sherman. 2005. Band 3 clustering promotes the exposure of neoantigens in Plasmodium falciparum-infected erythrocytes. Mol. Biochem. Parasitol. 142: 98-105. (Pubitemid 40720132)
18. Winograd, E., S. Eda, and I. W. Sherman. 2004. Chemical modifications of band 3 protein affect the adhesion of Plasmodium falciparum-infected erythrocytes to CD36. Mol. Biochem. Parasitol. 136: 243-248. (Pubitemid 38757992)
19. Rutella, S., C. Rumi, P. Puggioni, T. Barberi, A. Di Mario, L. M. Larocca, and G. Leone. 1999. Expression of thrombospondin receptor (CD36) in B-cell chronic lymphocytic leukemia as an indicator of tumor cell dissemination. Haematologica 84: 419-424. (Pubitemid 29473132)
20. Casey, J. R., D. M. Lieberman, and R. A. Reithmeier. 1989. Purification and characterization of band 3 protein. Methods Enzymol. 173: 494-512.
21. Yu, J., D. A. Fischman, and T. L. Steck. 1973. Selective solubilization of proteins and phospholipids from red blood cell membranes by nonionic detergents. J. Supramol. Struct. 1: 233-248.
22. Ding, Y., W. Jiang, Y. Su, H. Zhou, and Z. Zhang. 2004. Expression and purification of recombinant cytoplasmic domain of human erythrocyte band 3 with hexahistidine tag or chitin-binding tag in Escherichia coli. Protein Expr. Purif. 34: 167-175. (Pubitemid 38390562)
23. Hargreaves, W. R., K. N. Giedd, A. Verkleij, and D. Branton. 1980. Reassociation of ankyrin with band 3 in erythrocyte membranes and in lipid vesicles. J. Biol. Chem. 255: 11965-11972. (Pubitemid 11132212)
24. Crespo, M., F. Bosch, N. Villamor, B. Bellosillo, D. Colomer, M. Rozman, S. Marce, A. Lopez-Guillermo, E. Campo, and E. Montserrat. 2003. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N. Engl. J. Med. 348: 1764-1775. (Pubitemid 36514707)
25. Goodell, V., C. de la Rosa, M. Slota, B. MacLeod, and M. L. Disis. 2007. Sensitivity and specificity of tritiated thymidine incorporation and ELISPOT assays in identifying antigen specific T cell immune responses. BMC Immunol. 8: 21. (Pubitemid 47617927)
26. + T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 103: 4222-4231.
27. + regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses. J. Immunol. Methods 322: 1-11.
28. Sambrano, G. R., S. Parthasarathy, and D. Steinberg. 1994. Recognition of oxidatively damaged erythrocytes by a macrophage receptor with specificity for oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA 91: 3265-3269.
29. Hirano, K., Y. Miki, Y. Hirai, R. Sato, T. Itoh, A. Hayashi, M. Yamanaka, S. Eda, and M. Beppu. 2005. A multifunctional shuttling protein nucleolin is a macrophage receptor for apoptotic cells. J. Biol. Chem. 280: 39284-39293. (Pubitemid 41713883)
30. Casey, J. R., C. A. Pirraglia, and R. A. Reithmeier. 1992. Enzymatic deglycosylation of human Band 3, the anion transport protein of the erythrocyte membrane: effect on protein structure and transport properties. J. Biol. Chem. 267: 11940-11948.
31. Dazzi, F., E. D'Andrea, G. Biasi, G. De Silvestro, G. Gaidano, M. Schena, T. Tison, F. Vianello, A. Girolami, and F. Caligaris-Cappio. 1995. Failure of B cells of chronic lymphocytic leukemia in presenting soluble and alloantigens. Clin. Immunol. Immunopathol. 75: 26-32.
32. Yasukawa, M., T. Shiroguchi, A. Inatsuki, and Y. Kobayashi. 1988. Antigen presentation in an HLA-DR-restricted fashion by B-cell chronic lymphocytic leukemia cells. Blood 72: 102-108. (Pubitemid 18209290)
33. Van den Hove, L. E., S. W. Van Gool, P. Vandenberghe, M. Bakkus, K. Thielemans, M. A. Boogaerts, and J. L. Ceuppens. 1997. CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules. Leukemia 11: 572-580.
34. Ranheim, E. A., and T. J. Kipps. 1993. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177: 925-935.
35. Krackhardt, A. M., S. Harig, M. Witzens, R. Broderick, P. Barrett, and J. G. Gribben. 2002. T-cell responses against chronic lymphocytic leukemia cells: implications for immunotherapy. Blood 100: 167-173.
36. Rezvany, M. R., M. Jeddi-Tehrani, H. Rabbani, N. Lewin, J. Avila-Carino, A. Osterborg, H. Wigzell, and H. Mellstedt. 2000. Autologous T lymphocytes may specifically recognize leukaemic B cells in patients with chronic lymphocytic leukaemia. Br. J. Haematol. 111: 608-617. (Pubitemid 32009359)
37. Ge, Y., and M. T. Elghetany. 2005. CD36: a multiligand molecule. Lab. Hematol. 11: 31-37.
38. Febbraio, M., D. P. Hajjar, and R. L. Silverstein. 2001. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J. Clin. Invest. 108: 785-791. (Pubitemid 32880285)
39. Dumaswala, U. J., and T. J. Greenwalt. 1984. Human erythrocytes shed exocytic vesicles in vivo. Transfusion 24: 490-492.
40. Willekens, F. L., B. Roerdinkholder-Stoelwinder, Y. A. Groenen-Dopp, H. J. Bos, G. J. Bosman, A. G. van den Bos, A. J. Verkleij, and J. M. Werre. 2003. Hemoglobin loss from erythrocytes in vivo results from spleen-facilitated vesiculation. Blood 101: 747-751.
41. Sills, R. H., J. H. Tamburlin, N. J. Barrios, P. L. Yeagle, and C. A. Glomski. 1988. Physiologic formation of intracellular vesicles in mature erythrocytes. Am. J. Hematol. 28: 219-226.
42. Werre, J. M., F. L. Willekens, F. H. Bosch, L. D. de Haans, S. G. van der Vegt, A. G. van den Bos, and G. J. Bosman. 2004. The red cell revisited: matters of life and death. Cell. Mol. Biol. 50: 139-145.
43. + T cells in healthy individuals. Eur. J. Immunol. 31: 2660-2668.
44. Serreze, D. V., S. A. Fleming, H. D. Chapman, S. D. Richard, E. H. Leiter, and R. M. Tisch. 1998. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Immunol. 161: 3912-3918. (Pubitemid 28468965)
45. O'Neill, S. K., M. J. Shlomchik, T. T. Glant, Y. Cao, P. D. Doodes, and A. Finnegan. 2005. Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis. J. Immunol. 174: 3781-3788.
46. Mamula, M. J. 1998. Epitope spreading: the role of self peptides and autoantigen processing by B lymphocytes. Immunol. Rev. 164: 231-239.
47. Chesnut, R. W., S. M. Colon, and H. M. Grey. 1982. Antigen presentation by normal B cells, B cell tumors, and macrophages: functional and biochemical comparison. J. Immunol. 128: 1764-1768. (Pubitemid 12193039)
48. Barker, R. N., and C. J. Elson. 1994. Multiple self epitopes on the Rhesus polypeptides stimulate immunologically ignorant human T cells in vitro. Eur. J. Immunol. 24: 1578-1582.
49. Snowden, N., I. Reynolds, K. Morgan, and L. Holt. 1997. T cell responses to human type II collagen in patients with rheumatoid arthritis and healthy controls. Arthritis Rheum. 40: 1210-1218. (Pubitemid 27430131)
50. Monti, P., M. Scirpoli, A. Rigamonti, A. Mayr, A. Jaeger, R. Bonfanti, G. Chiumello, A. G. Ziegler, and E. Bonifacio. 2007. Evidence for in vivo primed and expanded autoreactive T cells as a specific feature of patients with type 1 diabetes. J. Immunol. 179: 5785-5792.
51. Budinger, L., L. Borradori, C. Yee, R. Eming, S. Ferencik, H. Grosse-Wilde, H. F. Merk, K. Yancey, and M. Hertl. 1998. Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J. Clin. Invest. 102: 2082-2089. (Pubitemid 29018814)
52. Filion, M. C., C. Proulx, A. J. Bradley, D. V. Devine, R. P. Sekaly, F. Decary, and P. Chartrand. 1996. Presence in peripheral blood of healthy individuals of autoreactive T cells to a membrane antigen present on bone marrow-derived cells. Blood 88: 2144-2150.
53. Kuwana, M., T. A. Medsger, Jr., and T. M. Wright. 1995. T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors. J. Clin. Invest. 96: 586-596.
54. Scrivener, S., R. V. Goddard, H. D. Chapman, and A. G. Prentice. 2003. B-cell chronic lymphocytic leukaemia. J. Immunol. 44: 383-389.
55. Dai, Y. D., G. Carayanniotis, and E. Sercarz. 2005. Antigen processing by autoreactive B cells promotes determinant spreading. Cell. Mol. Immunol. 2: 169-175.
56. Jiao, Y. F., T. Okumiya, T. Saibara, Y. Kudo, and T. Sugiura. 2001. Erythrocyte creatine as a marker of excessive erythrocyte destruction due to hypersplenism in patients with liver cirrhosis. Clin. Biochem. 34: 395-398.
57. Christensen, B. E. 1975. Quantitative determination of splenic red blood cell destruction in patients with splenomegaly. Scand. J. Haematol. 14: 295-302.
58. Caligaris-Cappio, F. 2003. Role of the microenvironment in chronic lymphocytic leukaemia. Br. J. Haematol. 123: 380-388. (Pubitemid 37363477)
59. Lanzavecchia, A. 1995. How can cryptic epitopes trigger autoimmunity? J. Exp. Med. 181: 1945-1948.
60. Vidard, L., K. L. Rock, and B. Benacerraf. 1992. Heterogeneity in antigen processing by different types of antigen-presenting cells: effect of cell culture on antigen processing ability. J. Immunol. 149: 1905-1911.